ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Reneo Pharmaceuticals Inc

Reneo Pharmaceuticals Inc (RPHM)

1.50
-0.01
(-0.66%)
Closed September 23 4:00PM
1.50
0.00
(0.00%)
After Hours: 7:32PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.50
Bid
1.50
Ask
1.53
Volume
273,522
1.45 Day's Range 1.53
0.9801 52 Week Range 9.21
Market Cap
Previous Close
1.51
Open
1.45
Last Trade
96
@
1.5
Last Trade Time
Financial Volume
$ 406,566
VWAP
1.4864
Average Volume (3m)
152,791
Shares Outstanding
33,428,808
Dividend Yield
-
PE Ratio
-0.65
Earnings Per Share (EPS)
-2.32
Revenue
-
Net Profit
-77.39M

About Reneo Pharmaceuticals Inc

Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing ... Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Reneo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RPHM. The last closing price for Reneo Pharmaceuticals was $1.51. Over the last year, Reneo Pharmaceuticals shares have traded in a share price range of $ 0.9801 to $ 9.21.

Reneo Pharmaceuticals currently has 33,428,808 shares outstanding. The market capitalization of Reneo Pharmaceuticals is $50.48 million. Reneo Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.65.

RPHM Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.1410.29411764711.361.581.25015319621.42417659CS
4-0.04-2.59740259741.541.691.25011941811.44952437CS
12-0.09-5.660377358491.591.691.25011527911.47282377CS
26-0.15-9.090909090911.651.931.25011950411.58557512CS
52-5.86-79.61956521747.369.210.98014176372.19277365CS
156-6.1-80.26315789477.611.2950.98011888213.09853673CS
260-13.8-90.196078431415.316.830.98011761873.62005385CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BNZIBanzai International Inc
$ 5.645
(96.01%)
61.39M
ZJYLJin Medical International Ltd
$ 3.975
(50.00%)
1.24M
ANEBAnebulo Pharmaceuticals Inc
$ 2.9001
(39.43%)
78.85k
XPONExpion360 Inc
$ 0.081
(39.18%)
1.46B
AENTAlliance Entertainment Holding Corporation
$ 2.74
(34.31%)
4.23M
GSIWGarden Stage Ltd
$ 1.34
(-82.89%)
26.44M
CRBPCorbus Pharmaceuticals Holdings Inc
$ 19.51
(-62.26%)
12.29M
LGCBLinkage Global Inc
$ 0.4183
(-57.70%)
2.16M
BFIBurgerFi International Inc
$ 0.0855
(-42.27%)
15.05M
SKYESkye Bioscience Inc
$ 3.17
(-42.26%)
5.14M
XPONExpion360 Inc
$ 0.081
(39.18%)
1.46B
NVDANVIDIA Corporation
$ 116.00
(-1.59%)
377.84M
AAPLApple Inc
$ 228.20
(-0.29%)
320.78M
INTCIntel Corporation
$ 21.84
(3.31%)
261.68M
VERBVerb Technology Company Inc
$ 0.0742
(33.45%)
178.65M

Your Recent History

Delayed Upgrade Clock